ASTRAZENECA PLC purchased 25.0% of their position (600K shares) of PHASEBIO PHARMACEUTICALS INC on the open market
Open‑market purchase worth $3.00M — a significant purchase. The strongest form of insider conviction signal.
Common Stock
Shares
+2.40M
Price / share
—
Trade value
—
% of position
Common Stock
Shares
+600K
Price / share
$5.00
Trade value
$3M
% of position
Net shares
+3M
Net value
$3M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 10/22/2018 | C · Conversion | +2.40M | — | — | New position | 0.00 | 2.40M |
| Common Stock Indirect | 10/22/2018 | P · Purchase | +600K | $5.00 | $3M | 25.0% | 2.40M | 3M |
| Total | +3M | $3M | ||||||
Warrants to Purchase Series C-1 Preferred Stock
Series C-1 Preferred Stock
113.89K shares
Shares
−113.89K
Strike price
0.12
Held after
0.00
Exercisable
—
Series C-1 Preferred Stock
Common Stock
113.89K shares
Shares
+113.89K
Strike price
Held after
1.67M
Exercisable
—
Series C-1 Preferred Stock
Common Stock
2.73K shares
Shares
−2.73K
Strike price
Held after
1.66M
Exercisable
—
Series C-1 Preferred Stock
Common Stock
1.66M shares
Shares
−1.66M
Strike price
Held after
0.00
Exercisable
—
Series D Preferred Stock
Common Stock
740.34K shares
Shares
−740.34K
Strike price
Held after
0.00
Exercisable
—
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Warrants to Purchase Series C-1 Preferred Stock Indirect | Series C-1 Preferred Stock113.89K shares | 10/22/2018 | X · X | −113.89K | 0.12 | — | 0.00 |
| Series C-1 Preferred Stock Indirect | Common Stock113.89K shares | 10/22/2018 | X · X | +113.89K | — | 1.67M | |
| Series C-1 Preferred Stock Indirect | Common Stock2.73K shares | 10/22/2018 | S · Sale | −2.73K | — | 1.66M | |
| Series C-1 Preferred Stock Indirect | Common Stock1.66M shares | 10/22/2018 | C · Conversion | −1.66M | — | 0.00 | |
| Series D Preferred Stock Indirect | Common Stock740.34K shares | 10/22/2018 | C · Conversion | −740.34K | — | 0.00 |